H.C. Wainwright raised the firm’s price target on electroCore (ECOR) to $22 from $15 and keeps a Buy rating on the shares after the firm ...

H.C. Wainwright lowered the firm’s price target on Instil Bio (TIL) to $110 from $120 and keeps a Buy rating on the shares post the Q3 ...

Sensus Healthcare undertakes no obligation to revise or update any forward-looking statements, except as required by law. All forward-looking statements are subject to risks and uncertainties as ...

On Wednesday, Lexicon Pharmaceuticals Inc (LXRX) stock saw a decline, ending the day at $1.09 which represents a decrease of $-0.10 or -8.40% from the prior close of $1.19. The stock opened at $1.18 ...

SoundHound AI stock continued its roller-coaster ride on Thursday. SOUN stock bounded higher after getting a price-target ...

On Wednesday, Rockwell Medical Inc (RMTI) stock saw a decline, ending the day at $2.63 which represents a decrease of $-0.20 or -7.07% from the prior close of $2.83. The stock opened at $3 and touched ...

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

Vista Gold Corp. recently renewed its At-The-Market Offering Agreement ("ATM Agreement") with H.C. Wainwright & Co., LLC. In the course of ordinary business, Vista has maintained an ATM Agreement ...

Mako Mining Corp. ("Mako" or the "Company") announces that the TSX Venture Exchange (the "TSXV") has accepted its normal course issuer bid (the "NCIB") to purchase up to an aggregate of 3, ...

H.C. Wainwright reinstated coverage of Opus Genetics (IRD) with a Buy rating and $8 price target The firm believes inherited ...

Vista Gold Corp. (NYSE American and TSX: VGZ) recently renewed its At-The-Market Offering Agreement ("ATM Agreement") with H.C. Wainwright & Co., LLC ...

H.C. Wainwright downgraded Syros Pharmaceuticals (SYRS) to Neutral from Buy with a price target of $1, down from $6, after ...